Register: Bridging Formulation & Device: Integrated Supply Chain Strategies for US Pharma Manufacturing

ABOUT THE EVENT

Date: Wednesday, September 17, 2025 11am–12pm EDT
Event Location: Virtual

Join Travis Webb, CSO at Pharmaceutics International (Pii, a Jabil company), and Oliver Eden, Sr. Business Unit Director, Pharma Solutions at Jabil, for a high-level discussion on overcoming pharmaceutical supply chain challenges through end‑to‑end integration. Tailored for external manufacturing and CMC decision‑makers in mid‑to‑large pharma, this webinar will explore how harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products.

Featured Speakers

Oliver Eden, based in Malmesbury, Great Britain, is currently a Senior Business Unit Director at Jabil for their Pharmaceutical Solutions division. Oliver brings experience from previous roles at Nypro (now Jabil) and Catalent Pharma Solutions. He holds a Ph.D. in biomaterials engineering and master’s in mechanical engineering from the University of Exeter. With a robust skill set that includes pharmaceuticals, forecasting, new business development, product development, biotechnology and more.
Travis Webb comes to Pii with over 17 years of experience in both analytical and formulation contract development across multiple dosage forms including injectables, liquid pulmonary, oral solids and liquids, and topical drug products. During his career he has developed over 20 approved drug generic and NDA drug products and helped bring numerous INDs to various clinical stages. Travis also has extensive experience with QBD and pediatric drug product development for both the U.S. and Europe, supporting IND/NDA filings and communicating with regulatory agencies.

Travis holds an M.S. in Pharmaceutical Chemistry from the University of Florida and a B.S in Biochemistry from Troy University.

Moderator

Lori Ellis[square]
Lori Ellis
Head of Insights | BioSpace
Lori is the head of insights at BioSpace. She analyzes and comments on industry trends for BioSpace and clients. She creates engaging content for clients to support their marketing objectives. She has been part of an award-winning marketing team and has won a Muse Creative award, a Vega award and several Adobe awards in collaborative team projects for her audio narration work. Her experience in the television/film and audio industries benefits both BioSpace and partners through her moderation and hosting of live and virtual events. While she has covered all elements of the drug development process, her primary focuses are women’s health issues, the economic climate, and the ever-evolving impact of technology – specifically artificial intelligence – on the pharmaceutical industry.

MORE EVENTS
Real-world data offers powerful opportunities to study disease progression, treatment safety and effectiveness, and patient outcomes—but some of the most clinically meaningful details are buried in unstructured sources like clinical notes and diagnostic reports.
Wednesday, August 27, 2025 1–2pm EDT
 · 
Virtual